iBio, Inc. Statistics
Total Valuation
iBio, Inc. has a market cap or net worth of $16.70 million. The enterprise value is $11.49 million.
Important Dates
The next estimated earnings date is Tuesday, November 11, 2025, after market close.
Earnings Date | Nov 11, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
iBio, Inc. has 19.65 million shares outstanding. The number of shares has increased by 174.05% in one year.
Current Share Class | 19.65M |
Shares Outstanding | 19.65M |
Shares Change (YoY) | +174.05% |
Shares Change (QoQ) | +45.91% |
Owned by Insiders (%) | 4.07% |
Owned by Institutions (%) | 16.37% |
Float | 18.61M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 22.56 |
Forward PS | n/a |
PB Ratio | 1.12 |
P/TBV Ratio | 2.05 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 28.73 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.24.
Current Ratio | 1.59 |
Quick Ratio | 1.42 |
Debt / Equity | 0.24 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -87.75 |
Financial Efficiency
Return on equity (ROE) is -101.52% and return on invested capital (ROIC) is -52.14%.
Return on Equity (ROE) | -101.52% |
Return on Assets (ROA) | -44.79% |
Return on Invested Capital (ROIC) | -52.14% |
Return on Capital Employed (ROCE) | -108.92% |
Revenue Per Employee | $20,000 |
Profits Per Employee | -$918,850 |
Employee Count | 20 |
Asset Turnover | 0.02 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.20% in the last 52 weeks. The beta is 0.89, so iBio, Inc.'s price volatility has been lower than the market average.
Beta (5Y) | 0.89 |
52-Week Price Change | -61.20% |
50-Day Moving Average | 0.78 |
200-Day Moving Average | 1.89 |
Relative Strength Index (RSI) | 53.65 |
Average Volume (20 Days) | 397,249 |
Short Selling Information
The latest short interest is 903,899, so 4.60% of the outstanding shares have been sold short.
Short Interest | 903,899 |
Short Previous Month | 1.13M |
Short % of Shares Out | 4.60% |
Short % of Float | 4.86% |
Short Ratio (days to cover) | 0.45 |
Income Statement
In the last 12 months, iBio, Inc. had revenue of $400,000 and -$18.38 million in losses. Loss per share was -$1.75.
Revenue | 400,000 |
Gross Profit | 400,000 |
Operating Income | -18.60M |
Pretax Income | -18.38M |
Net Income | -18.38M |
EBITDA | -17.83M |
EBIT | -18.60M |
Loss Per Share | -$1.75 |
Full Income Statement Balance Sheet
The company has $8.58 million in cash and $3.57 million in debt, giving a net cash position of $5.01 million or $0.25 per share.
Cash & Cash Equivalents | 8.58M |
Total Debt | 3.57M |
Net Cash | 5.01M |
Net Cash Per Share | $0.25 |
Equity (Book Value) | 14.88M |
Book Value Per Share | 0.77 |
Working Capital | 3.62M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$15.30 million and capital expenditures -$16,000, giving a free cash flow of -$15.32 million.
Operating Cash Flow | -15.30M |
Capital Expenditures | -16,000 |
Free Cash Flow | -15.32M |
FCF Per Share | -$0.78 |
Full Cash Flow Statement Margins
Gross Margin | 100.00% |
Operating Margin | -4,650.50% |
Pretax Margin | -4,594.25% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
iBio, Inc. does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -174.05% |
Shareholder Yield | -174.05% |
Earnings Yield | -111.36% |
FCF Yield | -92.84% |
Analyst Forecast
The average price target for iBio, Inc. is $5.50, which is 547.21% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $5.50 |
Price Target Difference | 547.21% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on November 29, 2023. It was a reverse split with a ratio of 1:20.
Last Split Date | Nov 29, 2023 |
Split Type | Reverse |
Split Ratio | 1:20 |
Scores
iBio, Inc. has an Altman Z-Score of -20.85 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -20.85 |
Piotroski F-Score | 2 |